Saudi Journal of Kidney Diseases and Transplantation

ORIGINAL ARTICLE
Year
: 2019  |  Volume : 30  |  Issue : 6  |  Page : 1381--1388

Chemerin level and the relation to insulin resistance in chronic kidney disease


Sahier Omar El-Khashab1, Mona Gamil1, Ahmed Yamany Ali1, Omar El-Khashab1, Mohamed El-Khatib1, Kariman Mohamed1, Amal El-Shehaby2, Soha Talat Hamed3 
1 Department of Internal Medicine and Nephrology, Kasr Al-Ainy Cairo University, Cairo, Egypt
2 Department of Clinical Pathology, Kasr Al-Ainy Cairo University, Cairo, Egypt
3 Department of Radiology, Kasr Al-Ainy Cairo University, Cairo, Egypt

Correspondence Address:
Ahmed Yamany Ali
Department of Internal Medicine and Nephrology, Kasr Al-Ainy Cairo University, Cairo
Egypt

Chemerin has been associated with different components of the metabolic syndrome, including hypertension, hyperlipidemia, and insulin resistance (IR). The aim of this study was to evaluate serum chemerin level in chronic kidney disease (CKD) patients and its relation to IR. This study was conducted on 80 participants who were classified into three groups: Group I (30 CKD patients with mean age 53 ± 12 years), Group II (30 patients with end-stage renal disease on regular hemodialysis with mean age 48 ± 14.8 years) and Group III having 20 healthy age-and sex-matched controls. Serum chemerin level, fasting blood sugar, fasting insulin, HOMA-IR index calculation, urea, creatinine, estimated glomerular filtration rate, total cholesterol, and triglyceride were measured. Body composition was assessed by dual-energy X-ray absorptiometry. In Groups I and II, we found a significantly higher mean chemerin level compared to healthy controls (P <0.001), a highly significant positive correlation between mean chemerin level and the HOMA-IR index [r = 0.56, P <0.001/(r = 0.53, P <0.001)], and a highly significant negative correlation between mean chemerin level and GFR (r = -0.51, P <0.001/r = -0.46, P <0.001). In Group I, there was also a highly significant positive correlation between mean chemerin and systolic blood pressure (r = 0.31, P <0.05), diastolic blood pressure (r = 0.39, P <0.05 and creatinine (r = 0.34, P <0.05). Chemerin might be considered a uremic IR adipokine marker in CKD Stages 3, 4, and 5.


How to cite this article:
El-Khashab SO, Gamil M, Ali AY, El-Khashab O, El-Khatib M, Mohamed K, El-Shehaby A, Hamed ST. Chemerin level and the relation to insulin resistance in chronic kidney disease.Saudi J Kidney Dis Transpl 2019;30:1381-1388


How to cite this URL:
El-Khashab SO, Gamil M, Ali AY, El-Khashab O, El-Khatib M, Mohamed K, El-Shehaby A, Hamed ST. Chemerin level and the relation to insulin resistance in chronic kidney disease. Saudi J Kidney Dis Transpl [serial online] 2019 [cited 2021 Jun 15 ];30:1381-1388
Available from: https://www.sjkdt.org/article.asp?issn=1319-2442;year=2019;volume=30;issue=6;spage=1381;epage=1388;aulast=El-Khashab;type=0